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DRESS is a rare but life threatening drug allergic disease.
The value of skin tests, especially patch-tests (PT) for
defining the culprit drug were recently reported. Neverthe-
less DRESS has been associated with high risk of disease
flare linked to drug rechallenge (culprit drug or not) or
viral reactivation . In this study we analyzed the frequency
of patch test-induced DRESS flares. Method Between 01/
2009 and August 2013, patients with DRESS syndrome
(diagnosis score KARDAUN >5 : definite case) were hospi-
talized for drug allergic evaluation and received skin patch
tests (Patch tests and/or IDT) with 72h reading. In case of
DRESS flare blood viral load (HHV6, EBV, CMV), white
blood cells count , liver enzymes and kidney function were
performed. Results 68 DRESS were included. Among
them, 39 patients showed positive PT (57%) and 29 were
negative at the 72h reading. From the 39 PT positive
patients, 8 patients (20%) experienced a DRESS flare in the
form of a mild skin rash developing in the 48h following
the realization of skin tests. The rash started before the
72h reading in all cases. In two cases, general signs were
noted and in one case eosinophilia was found (760/mm3
N<500) but no patients reached the KARDAUN score >5.
Liver and kidney assays were normal. Viral blood PCR for
herpes viruses were negative at the onset of the relapse
and during the two following days. The culprit drugs were
dominated by betalactam antibiotics (4/8 : 50%). Skin
biopsies of the skin rash were compatible with a delayed
hypersensitivity reaction in all cases. Interestingly
4 patients (50%) were able to induce non specific rash
after introducing drugs unrelated to the culprit one with
negative blood herpes viral load. Conclusion Our study
demonstrates that positive skin tests may induce a mild
reactivation of DRESS in a noticeable proportion of
patients. The delay between skin tests and flare (in all
cases <48h) confirms that DRESS is a drug specific delayed
hypersensitivity reaction. The negativity of viral load does
not confirm the relation of DRESS flare with viral reactiva-
tion. Many hypotheses could explain the occurrence of
skin test-induced DRESS rash in these patients : T reg
dysfunction after DRESS syndrome , very strong T cell
sensitization in these patients, long term persistence of
drug in skin, T cell chronic pre-activation state, as
suggested by the frequency of non specific DRESS flare
following alternative drug administration. Clinicians
should be aware of the risk of skin test-induced DRESS
flares in order to optimize the management of these
patients during the allergological work up.
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